(Q30398970)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

0 references

1 reference

idiopathic pulmonary fibrosis

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Stefania Cerri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Carlo Vancheri

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Giacomo Sgalla

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

15

Andrea Cossarizza

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Elena Bianchini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Lara Gibellini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Elisa Persiani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Gloria Montanari

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Fabrizio Luppi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Cristiano Matteo Carbonelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Luigi Zucchi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Marialuisa Bocchino

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Alessandro Sanduzzi Zamparelli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Luca Richeldi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

9 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

Novel Mechanisms for the Antifibrotic Action of Nintedanib.

29 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Efficacy endpoints for idiopathic pulmonary fibrosis trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Update on therapeutic management of idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Fibrocytes in pulmonary fibrosis: a brief synopsis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Randomized trial to evaluate cardiometabolic and endothelial function in patients with plasma HIV-1 RNA suppression switching to darunavir/ritonavir with or without nucleoside analogues

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Peripheral blood biomarkers in idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

New mechanisms of pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Fibrocytes in lung disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Angiogenic cytokines in patients with idiopathic interstitial pneumonia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Circulating fibrocytes: collagen-secreting cells of the peripheral blood

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Fibrocytes: a unique cell population implicated in wound healing

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640202

Idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0515-0

Cooperation between human fibrocytes and endothelial colony-forming cells increases angiogenesis via the CXCR4 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0515-0

Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0515-0

Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0515-0

Imbalance of circulating endothelial cells and progenitors in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0515-0

Idiopathic pulmonary fibrosis: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0515-0

Peripheral blood fibrocytes: differentiation pathway and migration to wound sites

21 January 2018

1 reference

12 December 2020

Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis

1 reference

12 December 2020

Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study

1 reference

12 December 2020

Identification of Fibrocytes in Peripheral Blood

1 reference

12 December 2020

10.1186/S12916-015-0515-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

26552487

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26552487%20AND%20SRC:MED&resulttype=core&format=json